HLA‑B27 misfolding and spondyloarthropathies

References

• Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000; 59:883 - 886
   PubMed Web of Science ®Google Scholar
• Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, et al. Whole-genome screening in ankylosing spondylitis: Evidence of NonMHC genetic-susceptibility loci. Am J Hum Genet 2001; 68:918 - 926
   PubMed Web of Science ®Google Scholar
• Zhang G, Luo J, Bruckel J, Weisman MA, Schumacher HR, Khan MA, et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum 2004; 50:2246 - 2254
   PubMed Web of Science ®Google Scholar
• Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445:881 - 885
   PubMed Web of Science ®Google Scholar
• Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39:1329 - 1337
   PubMed Web of Science ®Google Scholar
• Reveille JD. Major histocompatibility genes and ankylosing spondylitis. Best Pract Res Clin Rheumatol 2006; 20:601 - 609
   PubMed Web of Science ®Google Scholar
• Brown MA. Non-major-histocompatibility-complex genetics of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2006; 20:611 - 621
   PubMed Web of Science ®Google Scholar
• Smith JA, Marker-Hermann E, Colbert RA. Pathogenesis of ankylosing spondylitis: Current concepts. Best Pract Res Clin Rheumatol 2006; 20:571 - 591
   PubMed Web of Science ®Google Scholar
• Lopez de Castro JA. HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 2007; 108:27 - 33
   PubMed Web of Science ®Google Scholar
• Breban M, Hacquard-Bouder C, Falgarone G. Animal models of HLA-B27-associated diseases. Curr Mol Med 2004; 4:31 - 40
   PubMed Web of Science ®Google Scholar
• Kievits F, Ivanyi P, Krimpenfort P, Berns A, Ploegh HL. HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature 1987; 329:447 - 449
   PubMed Web of Science ®Google Scholar
• Nickerson CL, Luthra HS, Savarirayan S, David CS. Susceptibility of HLA-B27 transgenic mice to yersinia enterocolitica infection. Hum Immunol 1990; 28:382 - 396
   PubMed Web of Science ®Google Scholar
• Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking β2-microglobulin: a model of human spondyloarthropathies. J Exp Med 1995; 182:1153 - 1158
   PubMed Web of Science ®Google Scholar
• Khare SD, Hansen J, Luthra HS, David CS. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human β2-microglobulin (b2m) double transgenic mice with disrupted mouse b2m. J Clin Invest 1997; 98:2746 - 2755
   Web of Science ®Google Scholar
• Khare SD, Bull MJ, Hanson J, Luthra HS, David CS. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. J Immunol 1998; 160:101 - 106
   PubMed Web of Science ®Google Scholar
• Kingsbury DJ, Mear JP, Witte DP, Taurog JD, Roopenian DC, Colbert RA. Development of spontaneous arthritis in β2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression. Arthritis Rheum 2000; 43:2290 - 2296
   PubMed Web of Science ®Google Scholar
• Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human b2-m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63:1099 - 1112
   PubMed Web of Science ®Google Scholar
• Taurog JD, Maika SD, Satumtira N, Dorris ML, McLean IL, Yanagisawa H, et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999; 169:209 - 223
   PubMed Web of Science ®Google Scholar
• Tran TM, Dorris ML, Satumtira N, Richardson JA, Hammer RE, Shang J, et al. Additional human beta(2)-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum 2006; 54:1317 - 1327
   PubMed Web of Science ®Google Scholar
• Hildebrand WH, Turnquist HR, Prilliman KR, Hickman HD, Schenk EL, McIlhaney MM, et al. HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. Hum Immunol 2002; 63:248 - 255
   PubMed Web of Science ®Google Scholar
• Yao Z, Volgger A, Scholz S, Albert ED. Sequence polymorphism in the HLA-B promoter region. Immunogenetics 1995; 41:343 - 353
   PubMed Web of Science ®Google Scholar
• Yu DY, Choo SY, Schaack T. Molecular mimicry in HLA-B27-related arthritis. Ann Int Med 1989; 111:581 - 591
   PubMed Web of Science ®Google Scholar
• Benjamin RJ, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11:137 - 142
   PubMedGoogle Scholar
• Allen RL, O'Callaghan CA, McMichael AJ, Bowness P. Cutting edge: HLA-B27 can form a novel beta2-microglobulin-free heavy chain homodimer structure. J Immunol 1999; 162:5045 - 5048
   PubMed Web of Science ®Google Scholar
• Malik P, Klimovitsky P, Deng LW, Boyson JE, Strominger JL. Uniquely conformed peptide-containing beta2-microglobulin-free heavy chains of HLA-B2705 on the cell surface. J Immunol 2002; 169:4379 - 4387
   PubMed Web of Science ®Google Scholar
• Edwards JCW, Bowness P, Archer JR. Jekyll and Hyde: The transformation of HLA-B27. Immunol Today 2000; 21:256 - 260
   PubMedGoogle Scholar
• Kollnberger S, Bird L, Sun MY, Retiere C, Braud VM, McMichael A, et al. Cell surface expression and immune receptor recogntion of HLA-B27 homodimers. Arth Rheum 2002; 46:2972 - 2982
   PubMed Web of Science ®Google Scholar
• Bird LA, Peh CA, Kollnberger S, Elliott T, McMichael AJ, Bowness P. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol 2003; 33:748 - 759
   PubMed Web of Science ®Google Scholar
• Allen RL, Trowsdale J. Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors. Curr Mol Med 2004; 4:59 - 65
   PubMed Web of Science ®Google Scholar
• Kollnberger S, Bird LA, Roddis M, Hacquard-Bouder C, Kubagawa H, Bodmer HC, et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 2004; 173:1699 - 1710
   PubMed Web of Science ®Google Scholar
• Mear JP, Schreiber KL, Münz C, Zhu X, Stevanovic S, Rammensee HG, et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol 1999; 163:6665 - 6670
   PubMed Web of Science ®Google Scholar
• Dangoria NS, DeLay ML, Kingsbury DJ, Mear JP, Uchanska-Ziegler B, Ziegler A, et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem 2002; 277:23459 - 23468
   PubMed Web of Science ®Google Scholar
• Colbert RA. HLA-B27 misfolding: A solution to the spondyloarthropathy conundrum?. Mol Med Today 2000; 6:224 - 230
   PubMedGoogle Scholar
• Turner MJ, Sowders DP, DeLay ML, Mohapatra R, Bai S, Smith JA, et al. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 2005; 175:2438 - 2448
   PubMed Web of Science ®Google Scholar
• Turner MJ, Delay ML, Bai S, Klenk E, Colbert RA. HLA-B27 upregulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum 2007; 56:215 - 223
   PubMed Web of Science ®Google Scholar
• Laitio P, Virtala M, Salmi M, Pelliniemi LJ, Yu DT, Granfors K. HLA-B27 modulates intracellular survival of salmonella enteritidis in human monocytic cells. Eur J Immunol 1997; 27:1331 - 1338
   PubMed Web of Science ®Google Scholar
• Virtala M, Kirveskari J, Granfors K. HLA-B27 modulates the survival of salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production. Infect Immun 1997; 65:4236 - 4242
   PubMed Web of Science ®Google Scholar
• Penttinen MA, Heiskanen KM, Mohapatra R, DeLay ML, Colbert RA, Sistonen L, et al. Enhanced intracellular replication of Salmonella enteritidis in HLA-B27-expressing human monocytic cells: Dependency on glutamic acid at position 45 in the B pocket of HLA-B27. Arthritis Rheum 2004; 50:2255 - 2263
   PubMed Web of Science ®Google Scholar
• Sahlberg AS, Penttinen MA, Heiskanen KM, Colbert RA, Sistonen L, Granfors K. Evidence that the p38 MAP kinase pathway is dysregulated in HLA-B27-expressing human monocytic cells: Correlation with HLA-B27 misfolding. Arthritis Rheum 2007; 56:2652 - 2662
   PubMed Web of Science ®Google Scholar
• Penttinen MA, Ekman PGranfors K. Non-antigen presenting effects of HLA-B27. Curr Mol Med 2004; 4:41 - 49
   PubMed Web of Science ®Google Scholar
• Bridges JP, Xu Y, Na CL, Wong HR, Weaver TE. Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C. J Cell Biol 2006; 172:395 - 407
   PubMed Web of Science ®Google Scholar
• Penttinen MA, Holmberg CI, Sistonen L, Granfors K. HLA-B27 modulates nuclear factor κB activation in human monocytic cells exposed to lipopolysaccharide. Arthritis Rheum 2002; 46:2172 - 2180
   PubMed Web of Science ®Google Scholar
• Gregersen N, Bross P, Vang S, Christensen JH. Protein Misfolding and Human Disease. Annu Rev Genomics Hum Genet 2006; 7:103 - 124
   PubMed Web of Science ®Google Scholar
• Hammer GE, Kanaseki T, Shastri N. The final touches make perfect the peptide-MHC class I repertoire. Immunity 2007; 26:397 - 406
   PubMed Web of Science ®Google Scholar
• Kienast A, Preuss M, Winkler M, Dick TP. Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin. Nat Immunol 2007; 8:864 - 872
   PubMed Web of Science ®Google Scholar
• Bouvier M. Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol Immunol 2003; 39:697 - 706
   PubMed Web of Science ®Google Scholar
• Dick TP. Assembly of MHC class I peptide complexes from the perspective of disulfide bond formation. Cell Mol Life Sci 2004; 61:547 - 556
   PubMed Web of Science ®Google Scholar
• Peh CA, Burrows SR, Barnden M, Khanna R, Cresswell P, Moss DJ, et al. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 1998; 8:531 - 542
   PubMed Web of Science ®Google Scholar
• Purcell AW, Gorman JJ, Garcia-Peydró M, Paradela A, Burrows SR, Talbo GH, et al. Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J Immunol 2001; 166:1016 - 1027
   PubMed Web of Science ®Google Scholar
• Dick TP, Bangia N, Peaper DR, Cresswell P. Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. Immunity 2002; 16:87 - 98
   PubMed Web of Science ®Google Scholar
• Serwold T, Gaw S, Shastri N. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat Immunol 2001; 2:644 - 651
   PubMed Web of Science ®Google Scholar
• Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 2002; 419:480 - 483
   PubMed Web of Science ®Google Scholar
• Hammer GE, Gonzalez F, Champsaur M, Cado D, Shastri N. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 2006; 7:103 - 112
   PubMed Web of Science ®Google Scholar
• York IA, Brehm MA, Zendzian S, Towne CF, Rock KL. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc Natl Acad Sci USA 2006; 103:9202 - 9207
   PubMed Web of Science ®Google Scholar
• Kanaseki T, Blanchard N, Hammer GE, Gonzalez F, Shastri N. ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity 2006; 25:795 - 806
   PubMed Web of Science ®Google Scholar
• Hammer GE, Gonzalez F, James E, Nolla H, Shastri N. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol 2007; 8:101 - 108
   PubMed Web of Science ®Google Scholar
• Cui X, Hawari F, Alsaaty S, Lawrence M, Combs CA, Geng W, et al. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 2002; 110:515 - 526
   PubMed Web of Science ®Google Scholar
• Cui X, Rouhani FN, Hawari F, Levine SJ. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol 2003; 171:6814 - 6819
   PubMed Web of Science ®Google Scholar
• Cui X, Rouhani FN, Hawari F, Levine SJ. An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem 2003; 278:28677 - 28685
   PubMed Web of Science ®Google Scholar
• Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005; 74:739 - 789
   PubMed Web of Science ®Google Scholar
• Perlmutter DH. Liver injury in alpha1-antitrypsin deficiency: An aggregated protein induces mitochondrial injury. J Clin Invest 2002; 110:1579 - 1583
   PubMed Web of Science ®Google Scholar
• Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K, Glimcher LH. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol 2003; 4:321 - 329
   PubMed Web of Science ®Google Scholar
• Oyadomari S, Araki E, Mori M. Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 2002; 7:335 - 345
   PubMed Web of Science ®Google Scholar
• Ron D. Proteotoxicity in the endoplasmic reticulum: Lessons from the Akita diabetic mouse. J Clin Invest 2002; 109:443 - 445
   PubMed Web of Science ®Google Scholar
• Southwood CM, Garbern J, Jiang W, Gow A. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 2002; 36:585 - 596
   PubMed Web of Science ®Google Scholar
• Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005; 52:1824 - 1835
   PubMed Web of Science ®Google Scholar
• Griffin TA, Reed AM. Pathogenesis of myositis in children. Curr Opin Rheumatol 2007; 19:487 - 491
   PubMed Web of Science ®Google Scholar
• Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, et al. Conditional upregulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 2000; 97:9209 - 9214
   PubMed Web of Science ®Google Scholar
• Colbert RA, Rowland-Jones SL, McMichael AJ, Frelinger JA. Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide. Proc Natl Acad Sci USA 1993; 90:6879 - 6883
   PubMed Web of Science ®Google Scholar
• Meusser B, Hirsch C, Jarosch E, Sommer T. ERAD: the long road to destruction. Nat Cell Biol 2005; 7:766 - 772
   PubMed Web of Science ®Google Scholar
• Tran TM, Satumtira N, Dorris ML, May E, Wang A, Furuta E, et al. HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP. J Immunol 2004; 172:5110 - 5119
   PubMed Web of Science ®Google Scholar
• Antoniou AN, Ford S, Taurog JD, Butcher GW, Powis SJ. Formation of HLA-B27 homodimers and their relationship to assembly kinetics. J Biol Chem 2004; 279:8895 - 8902
   PubMed Web of Science ®Google Scholar
• Colbert RA. The immunobiology of HLA-B27: variations on a theme. Curr Mol Med 2004; 4:21 - 30
   PubMed Web of Science ®Google Scholar
• Whelan MA, Archer JR. Chemical reactivity of an HLA-B27 thiol group. Eur J Immunol 1993; 23:3278 - 3285
   PubMed Web of Science ®Google Scholar
• Kostyu DD, Hannick LI, Traweek JL, Ghanayem M, Heilpern D, Dawson DV. HLA class I polymorphism: Structure and function and still questions. Hum Immunol 1997; 57:1 - 18
   PubMed Web of Science ®Google Scholar
• Breban M, Hammer RE, Richardson JA, Taurog JD. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 1993; 178:1607 - 1616
   PubMed Web of Science ®Google Scholar
• Breban M, Fernández-Sueiro JL, Richardson JA, Hadavand RR, Maika SD, Hammer RE, et al. T-cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 1996; 156:794 - 803
   PubMed Web of Science ®Google Scholar
• May E, Dorris ML, Satumtira N, Iqbal I, Rehman MI, Lightfoot E, et al. CD8ab T-cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol 2003; 170:1099 - 1105
   PubMed Web of Science ®Google Scholar
• Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr, Balish E, et al. Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis and arthritis in HLA-B27/human β2 microglobulin transgenic rats. J Clin Invest 1996; 98:945 - 953
   PubMed Web of Science ®Google Scholar
• Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 1999; 67:2969 - 2974
   PubMed Web of Science ®Google Scholar
• Boyle LH, Goodall JC, Opat SS, Gaston JS. The recognition of HLA-B27 by human CD4+ T-lymphocytes. J Immunol 2001; 167:2619 - 2624
   PubMed Web of Science ®Google Scholar
• Boyle LH, Goodall JC, Gaston JS. Major histocompatibility complex class I-restricted alloreactive CD4+ T-cells. Immunology 2004; 112:54 - 63
   PubMed Web of Science ®Google Scholar
• Roddis M, Carter RW, Sun MY, Weissensteiner T, McMichael AJ, Bowness P, et al. Fully functional HLA B27-restricted CD4+ as well as CD8+ T-cell responses in TCR transgenic mice. J Immunol 2004; 172:155 - 161
   PubMed Web of Science ®Google Scholar
• Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8:519 - 529
   PubMed Web of Science ®Google Scholar
• Lin W, Harding HP, Ron D, Popko B. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol 2005; 169:603 - 612
   PubMed Web of Science ®Google Scholar
• Smith JA, Turner MJ, DeLay ML, Kleck EI, Sowders DP, Colbert RA. Endoplasmic reticulum stress-induced and the unfolded protein response are linked to synergistic IFNβ induction via X-box binding protein-1. Eur J Immunol 2008; 38:1194 - 1203
   PubMed Web of Science ®Google Scholar
• Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 2003; 23:7448 - 7459
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Takaoka A. A weak signal for strong responses: Interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2001; 2:378 - 386
   PubMed Web of Science ®Google Scholar
• Montoya M, Schiavoni G, Mattei F, Gresser I, Belardelli F, Borrow P, et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 2002; 99:3263 - 3271
   PubMed Web of Science ®Google Scholar
• Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates EE, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005; 201:1435 - 1446
   PubMed Web of Science ®Google Scholar
• Seimon TA, Obstfeld A, Moore KJ, Golenbock DT, Tabas I. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci USA 2006; 103:19794 - 19799
   PubMed Web of Science ®Google Scholar
• Li Y, Schwabe RF, DeVries-Seimon T, Yao PM, Gerbod-Giannone MC, Tall AR, et al. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factoralpha and interleukin-6: model of NFkappaB and map kinase-dependent inflammation in advanced atherosclerosis. J Biol Chem 2005; 280:21763 - 21772
   PubMed Web of Science ®Google Scholar
• Colbert RA, Turner MJ, DeLay ML, Smith JA, Klenk EI, Sowders DP, et al. HLA-B27 misfolding activates the Il-23/Il-17 axis via the unfolded protein response in transgenic rats: evidence for a novel mechanism of inflammation. Arth Rheum 2007; 54:515
   Google Scholar
• Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145 - 173
   PubMed Web of Science ®Google Scholar
• Bottomly K. A functional dichotomy in CD4+ T-lymphocytes. Immunol Today 1988; 9:268 - 274
   PubMedGoogle Scholar
• Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: Master regulators of innate and adaptive immunity. Immunol Rev 2004; 202:96 - 105
   PubMed Web of Science ®Google Scholar
• Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T-cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123 - 1132
   PubMed Web of Science ®Google Scholar
• Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T-cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133 - 1141
   PubMed Web of Science ®Google Scholar
• Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T-cell lineages. Annu Rev Immunol 2007; 25:821 - 852
   PubMed Web of Science ®Google Scholar
• Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421:744 - 748
   PubMed Web of Science ®Google Scholar
• Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006; 116:1317 - 1326
   PubMed Web of Science ®Google Scholar
• Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, et al. IL-23 is essential for T-cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116:1310 - 1316
   PubMed Web of Science ®Google Scholar
• Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R, et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006; 25:309 - 318
   PubMed Web of Science ®Google Scholar
• Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445:648 - 651
   PubMed Web of Science ®Google Scholar
• Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, et al. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology (Oxford) 2006; 45:414 - 420
   PubMed Web of Science ®Google Scholar
• Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171:6173 - 6177
   PubMed Web of Science ®Google Scholar
• Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21:467 - 476
   PubMed Web of Science ®Google Scholar
• Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441:231 - 234
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, et al. TGFbeta and IL-6 drive the production of IL-17 and IL-10 by T-cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007; 8:1390 - 1397
   PubMed Web of Science ®Google Scholar
• Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126:1121 - 1133
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T-cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278:1910 - 1914
   PubMed Web of Science ®Google Scholar
• Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T-cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233 - 240
   PubMed Web of Science ®Google Scholar
• Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007; 25:221 - 242
   PubMed Web of Science ®Google Scholar
• Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204:1849 - 1861
   PubMed Web of Science ®Google Scholar
• Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17-producing helper T-cells. Nat Immunol 2007; 8:950 - 957
   PubMed Web of Science ®Google Scholar
• Wiekowski MT, Leach MW, Evans EW, Sullivan L, Chen SC, Vassileva G, et al. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility and premature death. J Immunol 2001; 166:7563 - 7570
   PubMed Web of Science ®Google Scholar
• Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 1999; 17:189 - 220
   PubMed Web of Science ®Google Scholar
• Taurog JD. The mystery of HLA-B27: if it isn't one thing, it's another. Arthritis Rheum 2007; 56:2478 - 2481
   PubMed Web of Science ®Google Scholar
• Olivieri I, Padula A, Cianco G, Moro L, Durante E, Guadiano C, et al. The HLA-B* 2709 subtype in a patient with undifferentiated spondarthritis. Ann Rheum Dis 2000; 59:654 - 655
   PubMed Web of Science ®Google Scholar
• Olivieri I, Ciancio G, Padula A, Gaudiano C, Masciandaro S, Moro L, et al. The B*2709 subtype does not give absolute protection against spondyloarthropathy. Arthritis Rheum 2000; 43:265
   Google Scholar
• Olivieri I, D'Angelo S, Scarano E, Santospirito V, Padula A. The HLA-B*2709 subtype in a woman with early ankylosing spondylitis. Arthritis Rheum 2007; 56:2805 - 2807
   PubMed Web of Science ®Google Scholar
• Cauli A, Vacca A, Mameli A, Passiu G, Fiorillo MT, Sorrentino R, et al. A Sardinian patient with ankylosing spondylitis and HLA-B*2709 co-occurring with HLA-B*1403. Arthritis Rheum 2007; 56:2807 - 2809
   PubMed Web of Science ®Google Scholar
• Fiorillo MT, Cauli A, Carcassi C, Bitti PP, Vacca A, Passiu G, et al. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for pathogenesis. Arth Rheum 2003; 48:1385 - 1389
   PubMed Web of Science ®Google Scholar
• Taurog JD. HLA-DR4 and the spondyloarthropathies. Ann Rheum Dis 2002; 61:193 - 194
   PubMed Web of Science ®Google Scholar
• López-Larrea C, Sujirachato K, Mehra NK, Chiewsilp P, Isarangkura D, Kanga U, et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis: evidence for new associations. Tissue Antigens 1995; 45:169 - 176
   PubMed Web of Science ®Google Scholar
• Gonzalez-Roces S, Alvarez MV, Gonzalez S, Dieye A, Makni H, Woodfield DG, et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997; 49:116 - 123
   PubMed Web of Science ®Google Scholar
• Hou TY, Chen HC, Chen CH, Chang DM, Liu FC, Lai JH. Usefulness of human leucocyte antigen-B27 subtypes in predicting ankylosing spondylitis: Taiwan experience. Intern Med J 2007; 37:749 - 752
   PubMed Web of Science ®Google Scholar
• Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314:1461 - 1463
   PubMed Web of Science ®Google Scholar
• Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80:273 - 290
   PubMed Web of Science ®Google Scholar